Jim Momtazee's Montes Archimedes Acquisition Corp. combines with Roivant Sciences in $7.3b deal

The transaction is expected to deliver up to $611 million of gross proceeds to fund discovery and development programs at Roviant, a biopharmaceutical company.

DealsHealthcareBriefs